Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 30(25):3065-3070
- Year
- 2012
- Research Committee(s)
- Brain
- PMID
- PMID22851558
- PMC
- PMC3732006
- Study Number(s)
- R9802
Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802
- Journal / Conference
- ESTRO 31 (May 9-12, 2012, Barcelona, Spain), poster, abst. PO-0782;
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0713
Target delineation in rectal cancer radiotherapy radiobiological consequences of atlas implementation
- Journal / Conference
- J Clin Oncol 30: (suppl; abstr 3545), poster
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
Comparative effectiveness of sphincter-sparing surgery (SSS) versus abdomino-perineal resection (APR) in rectal cancer: Patient-reported outcomes (PROs) from NSABP R-04
- Journal / Conference
- J Clin Oncol 30:(suppl 4; abstr 391)
- Year
- 2012
- Research Committee(s)
- Gastrointestinal
Patient-reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04
- Journal / Conference
- Investigational New Drugs 29(2):352-359;
- Year
- 2011
- Research Committee(s)
- Head and Neck
- PMID
- PMID19937365
- PMC
- PMC2892241
- Study Number(s)
- S0618
Phase II evaluation of eribulin mesylate (E7389 NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618
- Journal / Conference
- British Journal of Urology Internatonal, 108(5):693-699;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Do mixed histologic features affect survival benefit from neo-adjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer treated with radical cystectomy? A secondary analysis of Southwest Oncology Group-directed intergroup study (S8710) [PMID 21105991; PMC3117124
- Journal / Conference
- Journal of Clinical Oncology 29(8):1014-1021;
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S0012
SWOG 0012: a phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus G-CSF as neoadjuvant therapy for inflammatory and locally advanced breast cancer [PMID21220618; PMC3024910]
- Journal / Conference
- Cancer 117:4740-4746;
- Year
- 2011
- Research Committee(s)
- Melanoma
- PMID
- PMID21455999
- PMC
- PMC3129414
- Study Number(s)
- SWOG-9430
A phase II trial of complete resection for stage IV melanoma: results of Southwest Oncology Group (SWOG) clinical trial S9430
- Journal / Conference
- Urology 77(5):1172-1176; Epub 2011 Feb 21;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0032
Phase II evaluation of early oral estramustine, oral etoposide and intravenous paclitaxel combined with hormonal therapy in patients with high-risk metastatic prostate adenocarcinoma: Southwest Oncology Group (SWOG) S0032 [PMID21334731]
- Journal / Conference
- Journal of Clinical Oncology 29(15)2040-2045;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S9921